Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies

The COVID-19 pandemic has highlighted disparities in healthcare, particularly in the United States, even though disparities have existed since the organization of the modern healthcare system. Recruitment of p...

Source: Allergy, Asthma and Clinical Immunology - September 24, 2022 Category: Allergy & Immunology Authors: Timothy J. Craig, Rafael H. Zaragoza-Urdaz, H. Henry Li, Ming Yu, Hong Ren, Salom é Juethner and John Anderson Tags: Short report Source Type: research